New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs
نویسندگان
چکیده
منابع مشابه
Generic legislation of new psychoactive drugs.
New psychoactive drugs (NPDs, new psychoactive substances) enter the market all the time. However, it takes several months to ban these NPDs and immediate action is generally not possible. Several European countries and drug enforcement officers insist on a faster procedure to ban NPDs. Introduction of generic legislation, in which clusters of psychotropic drugs are banned in advance, has been ...
متن کاملAmphetamines, new psychoactive drugs and the monoamine transporter cycle
In monoaminergic neurons, the vesicular transporters and the plasma membrane transporters operate in a relay. Amphetamine and its congeners target this relay to elicit their actions: most amphetamines are substrates, which pervert the relay to elicit efflux of monoamines into the synaptic cleft. However, some amphetamines act as transporter inhibitors. Both compound classes elicit profound psyc...
متن کاملAwareness survey of so-called Dappou drugs or Kiken drugs (New Psychoactive Substances) among University Students in Japan
BACKGROUND Spread of new psychoactive substances (NPS) is a worldwide problem. In Japan, NPSs with psychoactive ingredients are called as "dappou drugs" or "kiken drugs." Their potential effect on the Japanese society cannot be ignored. FINDINGS We conducted an awareness survey of So-called Dappou Drugs or Kiken Drugs among the students of Ibaraki University, a national university in Japan, i...
متن کاملNEW DRUGS NEW DRUGS Efalizumab for Plaque Psoriasis
NEW DRUGS Efalizumab for Plaque Psoriasis Genentech, Inc., and Xoma, Ltd., have announced the approval of efalizumab (RaptivaTM) by the U.S. Food and Drug Administration (FDA) for the treatment of chronic, moderate-to-severe plaque psoriasis in adults age 18 or older who are candidates for systemic therapy or phototherapy. This is the first biological agent that is designed to provide continuou...
متن کاملNEW DRUGS NEW DRUGS Fusion Inhibitor for HIV
NEW DRUGS Fusion Inhibitor for HIV The Food and Drug Administration (FDA) has announced the accelerated approval of enfuvir tide (FuzeonTM, Roche) for use with other anti-HIV medications in adults and children ages six years and older with advanced human immunodeficiency virus (HIV) infection. Enfuvirtide is the first in a new class of medications called fusion inhibitors, which interfere with ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Drug Policy
سال: 2017
ISSN: 0955-3959
DOI: 10.1016/j.drugpo.2017.01.016